By Anora Mahmudova and Carla Mozee, MarketWatch

NEW YORK (MarketWatch) -- U.S. stocks advanced, pushing the Dow Jones Industrial Average above 17,000 and its previous closing record on Monday as investors welcomed better-than-expected earnings from Citigroup Inc. and a flurry of mergers and acquisitions.

The banking heavyweight's profit topped estimates, even as it reached a $7 billion settlement with the U.S. Justice Department over shoddy mortgage-backed securities. Shares jumped 4%.

The S&P 500 (SPX) rose 10 points, or 0.5%, higher at 1,977.50, with financial stocks leading the gains. The Dow Jones Industrial Average (DJI) added 123 points, or 0.7%, to 17,066.91, topping its previous record close level.

The Nasdaq Composite (RIXF) gained 24 points, or 0.5%, to 4,438.91.

Follow MarketWatch's live blog of today's stock-market action.

"This market has defied all odds and we are seeing a classic 18-month-long climb up the wall of worry, said Vince Lowry, CEO of RevenueShares.

"We expect the second half to be choppy and a 5-10% pullback would be healthy. However, the issue right now is that there are no sellers, as people do not want to miss out on the rally," Lowry added.

The pace of the second-quarter earnings season will move into high gear this week with results due from large companies in the financial and technology sectors, the two largest sectors in the S&P 500 index.

Citigroup Inc. (C): The bank said it would pay $7 billion to settle claims regarding sales of mortgages before the financial crisis. The company also beat consensus forecasts for second-quarter earnings and revenues. Shares rose 3.2%.

The banking sector and "valuations are going to remain the main focus for this week, as we will get the earnings from some of the biggest tycoons of Wall Street," said Naeem Aslam, chief market analyst at AvaTrade, in a note. "The expectations are high, and investors are hoping that these earnings will cement the optimism that growth is on track in the U.S. and that revenues are healthy."

There are no Federal Reserve speakers or data reports on the calendar Monday, though Fed Chairwoman Janet Yellen will field questions from Congress on Tuesday and Wednesday. This week will see the retail sales report for June on Tuesday, which could offer clues about whether consumers are starting to feel more optimistic. Also on the docket this week are reports on new home construction, manufacturing and consumer sentiment.

Monday lived up to its merger day status, with a flurry of companies announcing deals. Shares of drug maker AbbVie Inc.(ABBV) fell 0.7% after Shire PLC (SHPGY) said Monday it has received a new takeover offer from AbbVie, and that it's willing to recommend the deal, now valued at more than $53 billion, to its shareholders.

Mylan Inc. shares (MYL) tacked on 2.7% following news of the drug company's plan to buy a portion of Abbott Laboratories' (ABT) generics business in a deal valued at $5.3 billion.

Apple Inc. (AAPL): shares rallied 1.7% after analysts Barclays and Morgan Stanley lifted their target price on the stock to $110.

In the commodities market, crude oil futures(CLQ4) swung between small gains and losses after logging a third consecutive weekly decline. Gold futures(GCQ4) tumbled Monday as solid gains for stocks and lackluster physical demand prompted investors to book profits on recent gains.

Asian stocks overnight finished broadly higher, with Tokyo's Nikkei Average ending up by 0.9%. European stocks rose as fears about the soundness of Portuguese banks receded.

More news from MarketWatch:

Avoid a U.S. stock market meltdown and go global

Apple denies it's a threat to China's security

Chinese man builds his own Tesla-charging network

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Abbott Laboratories Charts.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Abbott Laboratories Charts.